Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus


  1. Published

    Trichurs suis ova theraphy in relapsing multiple sclerosis is safe but without signals of beneficial effect

    Voldsgaard, A., Bager, P., Garde, E., Åkeson, P., Leffers, A. M., Madsen, C. G., Kapel, Christian, Thamsborg, Stig Milan, Roepstorff, A. K., Melbye, M., Siebner, Hartwig Roman, Søndergaard, H. B., Sellebjerg, F. & Sørensen, Per Soelberg, 2015, In: Multiple Sclerosis Journal. 21, 13, 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis

    Mechelli, R., Umeton, R., Policano, C., Annibali, V., Coarelli, G., Ricigliano, V. A. G., Vittori, D., Fornasiero, A., Buscarinu, M. C., Romano, S., Salvetti, M., Ristori, G., Consortium, I. M. S. G. & Sørensen, Per Soelberg, 2013, In: P L o S One. 8, 5, 9 p., e63300.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    A Case of Malignant Lymphoma and Myasthenia Gravis

    Hansen, B. A., Sørensen, Per Soelberg, Lauritzen, Martin, Iversen, J., Laulund, S., Petrera, J. E., Nielsen, Jørgen & Paulson, Olaf B., 1 Jan 1983, In: Scandinavian Journal of Haematology. 31, 2, p. 155-160 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod

    Koch-Henriksen, N., Magyari, M., Sellebjerg, Finn Thorup & Sørensen, Per Soelberg, Feb 2017, In: Multiple Sclerosis. 23, 2, p. 234-241 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    A doubleblind, cross-over trial of intravenous immunoglobulin G in multiple sclerosis

    Sørensen, Per Soelberg, Wancher, B., Schreiber, K., Blinkenberg, M., Jensen, C. V. & Ravnborg, M., 1997, In: Multiple Sclerosis. 3, p. 145-8

    Research output: Contribution to journalJournal articleResearch

  6. Published

    A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility

    Damotte, V., Guillot-Noel, L., Patsopoulos, N. A., Madireddy, L., El Behi, M., De Jager, P. L., Baranzini, S. E., Cournu-Rebeix, I., Fontaine, B., International Multiple Sclerosis Genetics Consortium, I. M. S. G. C. & Sørensen, Per Soelberg, Mar 2014, In: Genes and Immunity. 15, 2, p. 126-132 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    A method for chrinoc registration of impulse conduction in the rat

    Ballegaard, Martin, Laursen, H. & Sørensen, Per Soelberg, 22 Sep 1998.

    Research output: Contribution to conferencePosterResearchpeer-review

  8. Published

    A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis

    Giovannoni, G., Comi, G., Cook, S., Rammohan, K., Rieckmann, P., Sørensen, Per Soelberg, Vermersch, P., Chang, P., Hamlett, A., Musch, B., Greenberg, S. J. & CLARITY study group, C. S. G., 4 Feb 2010, In: New England Journal of Medicine. 362, 5, p. 416-26 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    A prospective PET study of patients with glioblastoma multiforme

    Andersen, P. B., Blinkenberg, M., Lassen, Ulrik Niels, Kosteljanetz, M., Wagner, A., Poulsen, H. S., Sørensen, Per Soelberg & Paulson, Olaf B., Jun 2006, In: Acta Neurologica Scandinavica. 113, 6, p. 412-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

    Vollmer, T. L., Sørensen, Per Soelberg, Selmaj, K., Zipp, F., Havrdova, E., Cohen, J. A., Sasson, N., Gilgun-Sherki, Y., Arnold, D. L. & BRAVO Study Group, B. S. G., Apr 2014, In: Journal of Neurology. 261, 4, p. 773-783 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

    Marrie, R. A., Reider, N., Cohen, J., Stuve, O., Sørensen, Per Soelberg, Cutter, G., Reingold, S. C. & Trojano, M., Mar 2015, In: Multiple Sclerosis. 21, 3, p. 282-293 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  12. Published

    A systematic review of the incidence and prevalence of cancer in multiple sclerosis

    Marrie, R. A., Reider, N., Cohen, J., Stuve, O., Trojano, M., Sørensen, Per Soelberg, Reingold, S. C. & Cutter, G., Mar 2015, In: Multiple Sclerosis Journal. 21, 3, p. 294-304 11 p.

    Research output: Contribution to journalReviewResearchpeer-review

  13. Published

    A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis

    Marrie, R. A., Reider, N., Cohen, J., Stuve, O., Trojano, M., Cutter, G., Reingold, S. & Sørensen, Per Soelberg, Mar 2015, In: Multiple Sclerosis. 21, 3, p. 318-331 14 p.

    Research output: Contribution to journalReviewResearchpeer-review

  14. Published

    A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview

    Marrie, R. A., Cohen, J., Stuve, O., Trojano, M., Sørensen, Per Soelberg, Reingold, S., Cutter, G. & Reider, N., Mar 2015, In: Multiple Sclerosis Journal. 21, 3, p. 263-81 19 p.

    Research output: Contribution to journalReviewResearchpeer-review

  15. Published

    A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis

    Marrie, R. A., Reider, N., Cohen, J., Trojano, M., Sørensen, Per Soelberg, Cutter, G., Reingold, S. & Stuve, O., Mar 2015, In: Multiple Sclerosis Journal. 21, 3, p. 342-349 8 p.

    Research output: Contribution to journalReviewResearchpeer-review

  16. Published

    Activity Related Conduction Block in the Pyramidal Tract of the DA Rat During Chronic Experimental Allergic Enccephalomyelitis (C-EAE)

    Ballegaard, Martin, Laursen, H. & Sørensen, Per Soelberg, 2001, p. S502.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  17. Published

    Age and sex as determinants of treatment decisions in patients with relapsing-remitting MS

    Sørensen, Per Soelberg, Kopp, T. I., Joensen, H., Olsson, A., Sellebjerg, Finn Thorup & Magyari, M., 2021, In: Multiple Sclerosis and Related Disorders. 50, 102813.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Akut medicin og neurologi

    Feldt-Rasmussen, Ulla & Sørensen, Per Soelberg, 2012, Medicin. Lærebog i medicin. Baslund, B., Feldt-Rasmussen, U., Kastrup, J. & Soelberg Sørensen, P. (eds.). 1. ed. p. 1142-1173 31 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  19. Published

    Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

    Coles, A. J., Twyman, C. L., Arnold, D. L., Cohen, J. A., Confavreux, C., Fox, E. J., Hartung, H., Havrdova, E., Selmaj, K. W., Weiner, H. L., Miller, T., Fisher, E., Sandbrink, R., Lake, S. L., Margolin, D. H., Oyuela, P., Panzara, M. A., Compston, D. A. S., CARE-MS II investigators, C. I. I. & Sørensen, Per Soelberg, 2012, In: Lancet. 380, 9856, p. 1829-39 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655

    Søndergaard, H. B., Sellebjerg, Finn Thorup, Hillert, J., Olsson, T., Kockum, I., Lindén, M., Mero, I., Myhr, K., Celius, E. G., Harbo, H. F., Christensen, J. R., Börnsen, L., Sørensen, Per Soelberg & Oturai, A. B., 2011, In: European Journal of Human Genetics. 19, 10, p. 1100-3 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    An update on combination therapies for multiple sclerosis: where are we now?

    Sørensen, Per Soelberg, Magyari, Melinda & Sellebjerg, Finn Thorup, 2023, In: Expert Review of Neurotherapeutics. 23, 12, p. 1173-1187 15 p.

    Research output: Contribution to journalReviewResearchpeer-review

  22. Published

    Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Beecham, A. H., Patsopoulos, N. A., Xifara, D. K., Davis, M. F., Kemppinen, A., Cotsapas, C., Shah, T. S., Spencer, C., Booth, D., Goris, A., Oturai, A., Saarela, J., Fontaine, B., Hemmer, B., Martin, C., Zipp, F., D'Alfonso, S., Martinelli-Boneschi, F., Taylor, B., Harbo, H. F. & 174 others, Kockum, I., Hillert, J., Olsson, T., Ban, M., Oksenberg, J. R., Hintzen, R., Barcellos, L. F., Agliardi, C., Alfredsson, L., Alizadeh, M., Anderson, C., Andrews, R., Søndergaard, H. B., Baker, A., Band, G., Baranzini, S. E., Barizzone, N., Barrett, J., Bellenguez, C., Bergamaschi, L., Bernardinelli, L., Berthele, A., Biberacher, V., Binder, T., Blackburn, H., Bomfim, I. L., Brambilla, P., Broadley, S., Brochet, B., Brundin, L., Buck, D., Butzkueven, H., Caillier, S. J., Camu, W., Carpentier, W., Cavalla, P., Celius, E. G., Coman, I., Comi, G., Corrado, L., Cosemans, L., Cournu-Rebeix, I., Cree, B. A. C., Cusi, D., Damotte, V., Defer, G., Delgado, S. R., Deloukas, P., di Sapio, A., Dilthey, A. T., Donnelly, P., Dubois, B., Duddy, M., Edkins, S., Elovaara, I., Esposito, F., Evangelou, N., Fiddes, B., Field, J., Franke, A., Freeman, C., Frohlich, I. Y., Galimberti, D., Gieger, C., Gourraud, P., Graetz, C., Graham, A., Grummel, V., Guaschino, C., Hadjixenofontos, A., Hakonarson, H., Halfpenny, C., Hall, G., Hall, P., Hamsten, A., Harley, J., Harrower, T., Hawkins, C., Hellenthal, G., Hillier, C., Hobart, J., Hoshi, M., Hunt, S. E., Jagodic, M., Jel?i?, I., Jochim, A., Kendall, B., Kermode, A., Kilpatrick, T., Koivisto, K., Konidari, I., Korn, T., Kronsbein, H., Langford, C., Larsson, M., Lathrop, M., Lebrun-Frenay, C., Lechner-Scott, J., Lee, M. H., Leone, M. A., Leppä, V., Liberatore, G., Lie, B. A., Lill, C. M., Lindén, M., Link, J., Luessi, F., Lycke, J., Macciardi, F., Männistö, S., Manrique, C. P., Martin, R., Martinelli, V., Mason, D., Mazibrada, G., McCabe, C., Mero, I., Mescheriakova, J., Moutsianas, L., Myhr, K., Nagels, G., Nicholas, R., Nilsson, P., Piehl, F., Pirinen, M., Price, S. E., Quach, H., Reunanen, M., Robberecht, W., Robertson, N. P., Rodegher, M., Rog, D., Salvetti, M., Schnetz-Boutaud, N. C., Sellebjerg, Finn Thorup, Selter, R. C., Schaefer, C., Shaunak, S., Shen, L., Shields, S., Siffrin, V., Slee, M., Sørensen, Per Soelberg, Sorosina, M., Sospedra, M., Spurkland, A., Strange, A., Sundqvist, E., Thijs, V., Thorpe, J., Ticca, A., Tienari, P., van Duijn, C., Visser, E. M., Vucic, S., Westerlind, H., Wiley, J. S., Wilkins, A., Wilson, J., Winkelmann, J., Zajicek, J., Zindler, E., Haines, J. L., Pericak-Vance, M. A., Ivinson, A. J., Stewart, G., Hafler, D., Hauser, S. L., Compston, A., McVean, G., De Jager, P., Sawcer, S. J., McCauley, J. L. & (IMSGC), I. M. S. G. C., 2013, In: Nature Genetics. 45, 11, p. 1353-1360 8 p.

    Research output: Contribution to journalLetterResearchpeer-review

  23. Published

    Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis

    Sellebjerg, Finn Thorup, Blinkenberg, M. & Sørensen, Per Soelberg, 2020, In: CNS Drugs. 34, 3, p. 269-280 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  24. Published

    Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort

    Olsson, T., Achiron, A., Alfredsson, L., Berger, T., Brassat, D., Chan, A., Comi, G., Eraksoy, M., Hegen, H., Hillert, J., Jensen, P. E. H., Moiola, L., Myhr, K-M., Oturai, A., Schippling, S., Siva, A., Sorensen, P. S., Trampe, A-K., Weber, T., Potts, J. & 8 others, Plavina, T., Paes, D., Subramanyam, M., Wiendl, H., Dib, H., Uren, D., Hemmer, B. & Buck, D., 2013, In: Multiple Sclerosis. 19, 11, p. 1533-1538 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis

    Sørensen, Per Soelberg, 2022, In: CNS Drugs. 36, 6, p. 569-589 21 p.

    Research output: Contribution to journalReviewResearchpeer-review

  26. Published

    Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate

    Høgh, Peter, Oturai, A., Schreiber, K., Blinkenberg, M., Jørgensen, O. S., Ryder, L., Paulson, Olaf B., Sørensen, Per Soelberg & Knudsen, Gitte Moos, Aug 2000, In: Multiple Sclerosis Journal. 6, 4, p. 226-30 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS

    Pugliatti, M., Eskic, D., Mikolcić, T., Pitschnau-Michel, D., Myhr, K-M., Sastre-Garriga, J., Otero, S., Wieczynska, L., Torje, C., Holloway, E., Rienhoff, O., Friede, T., Buckow, K., Ellenberger, D., Hillert, J., Glaser, A-M. S., Flachenecker, P., Fuge, J., Schyns-Liharska, T., Kasilingam, E. & 4 others, Moretti, A., Thalheim, C., EUReMS Consortium, E. C. & Sørensen, Per Soelberg, 2012, In: Acta Neurologica Scandinavica. Supplementum. 126, 195, p. 24-30 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans

    Brambilla, P., Esposito, F., Lindstrom, E., Sorosina, M., Giacalone, G., Clarelli, F., Rodegher, M., Colombo, B., Moiola, L., Ghezzi, A., Capra, R., Collimedaglia, L., Coniglio, G., Celius, E. G., Galimberti, D., Sørensen, P. S., Martinelli, V., Oturai, A. B., Harbo, H. F., Hillert, J. & 2 others, Comi, G. & Martinelli-Boneschi, F., 2012, In: Neuroscience Letters. 530, 2, p. 155-60 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    Association between age at onset of multiple sclerosis and vitamin D level-related factors

    Laursen, J. H., Søndergaard, H. B., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Oturai, A. B., 5 Jan 2016, In: Neurology. 86, 1, p. 88-93 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. Published

    Association between an interleukin-13 promoter polymorphism and atopy

    Hummelshoj, T., Bodtger, U., Datta, P., Malling, H. J., Oturai, A., Poulsen, Lars K., Ryder, L. P., Sørensen, Per Soelberg, Svejgaard, E. & Svejgaard, A., Oct 2003, In: European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics. 30, 5, p. 355-9 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP

    Hedegaard, C. J., Chen, N., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Leslie, R. G. Q., Bendtzen, K. & Nielsen, Claus Henrik, 1 Sep 2009, In: Immunology. 128, 1 Suppl, p. e451-61

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    Autologous hematopoietic stem cell transplantation of patients with aggressive relapsing-remitting multiple sclerosis: Danish nation-wide experience

    Jespersen, F., Petersen, S. L., Andersen, P., Sellebjerg, Finn Thorup, Magyari, M., Sørensen, Per Soelberg & Blinkenberg, M., 2023, In: Multiple Sclerosis and Related Disorders. 76, 7 p., 104829.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis

    the RADAR-CNS Consortium, T. R. C., 2023, In: Frontiers in Physiology. 14, 1145818.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Betydningen af neutraliserende antistoffer mod interferon-beta hos patienter med attakvis multipel sklerose

    Sørensen, Per Soelberg, Koch-Henriksen, N., Pedersen, C. R., Clemmesen, K. M., Bendtzen, K., Fredriksen, Jette Lautrup, Jensen, K., Kristensen, O., Petersen, T., Rasmussen, S., Ravnborg, M., Stenager, E. & Dansk Multipel Sklerose Gruppe, D. M. S. G., 4 Oct 2004, In: Ugeskrift for Laeger. 166, 41, p. 3606-9 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  35. Published

    Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis

    Siddi, S., Giné-Vázquez, I., Bailon, R., Matcham, F., Lamers, F., Kontaxis, S., Laporta, E., Garcia, E., Arranz, B., Dalla Costa, G., Guerrero, A. I., Zabalza, A., Buron, M. D., Comi, G., Leocani, L., Annas, P., Hotopf, M., Penninx, B. W. J. H., Magyari, M., Sørensen, P. S. & 27 others, Montalban, X., Lavelle, G., Ivan, A., Oetzmann, C., White, K. M., Difrancesco, S., Locatelli, P., Mohr, D. C., Aguiló, J., Narayan, V., Folarin, A., Dobson, R. J. B., Dineley, J., Leightley, D., Cummins, N., Vairavan, S., Ranjan, Y., Rashid, Z., Rintala, A., Girolamo, G. D., Preti, A., Simblett, S., Wykes, T., Myin-Germeys, I., Haro, J. M., PAB Members, P. M. & on behalf of the RADAR-CNS consortium, O. B. O. T. R. C., 2022, In: Journal of Clinical Medicine. 11, 23, 7163.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    Breakthrough disease during interferon-[beta] therapy in MS: No signs of impaired biologic response

    Hesse, D., Krakauer, M., Lund, H., Søndergaard, H. B., Langkilde, A., Ryder, L. P., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Langkilde, Annika Reynberg, 4 May 2010, In: Neurology. 74, 18, p. 1455-62 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  37. Published

    CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis

    Sellebjerg, Finn Thorup, Pedersen, Christian Ross, Koch-Henriksen, N., Sørensen, Per Soelberg, Fredriksen, Jette Lautrup, Bendtzen, K. & Sørensen, Torben Lykke, 1 Dec 2005, In: Multiple Sclerosis. 11, 6, p. 641-5 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published

    CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

    Romme Christensen, J., Börnsen, L., Khademi, M., Olsson, T., Jensen, P. E., Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 2013, In: Multiple Sclerosis.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Can we spot the IFNbeta nonresponders?1

    Sørensen, Per Soelberg, 2008, In: Neurology. 71, 24, p. 1936-1937 1 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. Published

    Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

    Lopes, R. D., Higano, C. S., Slovin, S. F., Nelson, A. J., Bigelow, R., Sørensen, Per Soelberg, Melloni, C., Goodman, S. G., Evans, C. P., Nilsson, J., Bhatt, D. L., Clarke, N. W., Olesen, T. K., Doyle-Olsen, B. T., Kristensen, H., Arney, L., Roe, M. T., Alexander, J. H. & PRONOUNCE Study Investigators, P. S. I., 2021, In: Circulation. 144, 16, p. 1295-1307 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

    Romme Christensen, J., Börnsen, L., Hesse, D., Krakauer, M., Sørensen, Per Soelberg, Søndergaard, H. B. & Sellebjerg, Finn Thorup, 2012, In: Journal of Neuroinflammation. 9, p. 215

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Cerebral blood flow in patients with normal-pressure hydrocephalus before and after shunting

    Vorstrup, S., Christensen, J., Gjerris, F., Sørensen, Per Soelberg, Thomsen, A. M. & Paulson, Olaf B., Mar 1987, In: Journal of Neurosurgery. 66, 3, p. 379-87 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  43. Published

    Cerebral metabolism in a case of multiple sclerosis with acute mental disorder

    Blinkenberg, M., Rune, K., Jønsson, A., Holm, S., Jensen, C. V., Paulson, Olaf B. & Sørensen, Per Soelberg, Nov 1996, In: Acta Neurologica Scandinavica. 94, 5, p. 310-3 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  44. Published

    Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study

    Blinkenberg, M., Mathiesen, H. K., Tscherning, T., Jønsson, A., Svarer, C., Holm, S., Sellebjerg, Finn Thorup, Paulson, Olaf B., Hanson, L. G. & Sørensen, Per Soelberg, Jan 2012, In: Neurological Research. 34, 1, p. 52-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  45. Published

    Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis

    Blinkenberg, M., Akeson, P., Sillesen, H., Lövgaard, S., Sellebjerg, Finn Thorup, Paulson, Olaf B., Siebner, H. R. & Sørensen, Per Soelberg, Dec 2012, In: Acta Neurologica Scandinavica. 126, 6, p. 421-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. Published

    Chronic comorbidity in multiple sclerosis is associated with lower incomes and dissolved intimate relationships

    Thormann, A., Sørensen, Per Soelberg, Koch-Henriksen, N., Thygesen, L. C., Laursen, B. & Magyari, M., Jun 2017, In: European Journal of Neurology. 24, 6, p. 825-834 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Clinical characteristics and use of disease modifying therapy in the nationwide Danish cohort of paediatric onset multiple sclerosis

    Erdal, J. L., Kopp, T. I., Blinkenberg, M., Petersen, T., Sørensen, Per Soelberg & Magyari, M., 2020, In: Multiple Sclerosis and Related Disorders. 37, 101431.

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

    Link, J., Ramanujam, R., Auer, M., Ryner, M., Hässler, S., Bachelet, D., Mbogning, C., Warnke, C., Buck, D., Hyldgaard Jensen, P. E., Sievers, C., Ingenhoven, K., Fissolo, N., Lindberg, R., Grummel, V., Donnellan, N., Comabella, M., Montalban, X., Kieseier, B., Soelberg Sørensen, P. & 12 others, Hartung, H., Derfuss, T., Lawton, A., Sikkema, D., Pallardy, M., Hemmer, B., Deisenhammer, F., Broët, P., Dönnes, P., Davidson, J., Fogdell-Hahn, A. & ABIRISK Consortium, A. C., Feb 2017, In: PLOS ONE. 12, 2, 18 p., e0170395.

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab

    Blinkenberg, M., Sellebjerg, Finn Thorup, Leffers, A. M., Madsen, C. G. & Sørensen, Per Soelberg, 2013, In: Multiple Sclerosis. 19, 9, p. 1226-1229 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  50. Published

    Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis

    Chalmer, T. A., Buron, M., Illes, Z., Papp, V., Theodorsdottir, A., Schäfer, J., Hansen, V., Asgari, N., Skejø, P. B., Jensen, H. B., Sørensen, Per Soelberg & Magyari, M., 2020, In: Journal of neurology, neurosurgery, and psychiatry. 91, 1, p. 67-74

    Research output: Contribution to journalJournal articleResearchpeer-review

  51. Published

    Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue

    Lund, H., Jønsson, A., Andresen, J. G., Rostrup, E., Paulson, Olaf B. & Sørensen, Per Soelberg, 2012, In: Acta Neurologica Scandinavica. 125, 5, p. 338-44 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  52. Published

    Comorbidity in Multiple Sclerosis

    Magyari, M. & Sørensen, Per Soelberg, 2020, In: Frontiers in Neurology. 11, 9 p., 851.

    Research output: Contribution to journalReviewResearchpeer-review

  53. Published

    Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality

    Thormann, A., Sørensen, Per Soelberg, Koch-Henriksen, N., Laursen, B. & Magyari, M., 17 Oct 2017, In: Neurology. 89, 16, p. 1668-1675 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  54. Published

    Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study

    Buron, M. D., Chalmer, T. A., Sellebjerg, Finn Thorup, Fredriksen, Jette Lautrup, Góra, M. K., Illes, Z., Kant, M., Mezei, Z., Petersen, T., Rasmussen, P. V., Roshanisefat, H., Hassanpour-Kalam-Roudy, H., Sejbæk, T., Tsakiri, A., Weglewski, Arkadiusz, Sørensen, Per Soelberg & Magyari, M., 2019, In: Neurology. 92, 16, p. e1811-e1820

    Research output: Contribution to journalJournal articleResearchpeer-review

  55. Published

    Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients

    Jensen, P. E. H., Sellebjerg, Finn Thorup, Søndergaard, H. B. & Sørensen, Per Soelberg, 2012, In: European Journal of Neurology. 19, 10, p. 1311-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  56. Published

    Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis

    Wu, X., Hanson, L. G., Skimminge, A., Sørensen, Per Soelberg, Paulson, Olaf B., Mathiesen, H. K. & Blinkenberg, M., Aug 2014, In: Neurological Research. 36, 8, p. 701-708 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  57. Published

    Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS

    Blinkenberg, M., Rune, K., Jensen, C. V., Ravnborg, M., Kyllingsbæk, Søren, Holm, S., Paulson, Olaf B. & Sørensen, Per Soelberg, 8 Feb 2000, In: Neurology. 54, 3, p. 558-64 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  58. Published

    Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients

    Hegen, H., Adrianto, I., Lessard, C. J., Millonig, A., Bertolotto, A., Comabella, M., Giovannoni, G., Guger, M., Hoelzl, M., Khalil, M., Fazekas, F., Killestein, J., Lindberg, R. L. P., Malucchi, S., Mehling, M., Montalbán, X., Rudzki, D., Schautzer, F., Sellebjerg, F., Sorensen, P. S. & 3 others, Deisenhammer, F., Steinman, L. & Axtell, R. C., Apr 2016, In: Neurology: Neuroimmunology & Neuroinflammation. 3, 2, 11 p., e202.

    Research output: Contribution to journalJournal articleResearchpeer-review

  59. Published

    D-vitamin. Opdatering af videnskabelig evidens for sygdomsforbyggelse og anbefalinger

    Mejborn, H., Andersen, R., Bredsdorff, L., Brot, C., Jakobsen, J., Krogholm, K. S., Mosekilde, L., Mølgaard, C., Olsen, A., Rejnmark, L., Snorgaard, O., Sørensen, Per Soelberg, Svensson, J., Thuesen, B. H., Wulf, H. C. O. & Rasmussen, L. B., 2010, 82 p.

    Research output: Book/ReportReportResearch

  60. Published

    Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)

    Sørensen, Per Soelberg, 2012, In: Multiple Sclerosis. 18, 8, p. 1070-2 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  61. Published

    Defining active progressive multiple sclerosis

    Sellebjerg, Finn Thorup, Börnsen, L., Ammitzbøll, C., Nielsen, Jørgen Erik, Vinther-Jensen, T., Hjermind, L. E., von Essen, M., Ratzer, R. L., Sørensen, Per Soelberg & Romme Christensen, J., 2017, In: Multiple Sclerosis. 23, 13, p. 1727-1735

    Research output: Contribution to journalJournal articleResearchpeer-review

  62. Published

    Defining the clinical course of multiple sclerosis: The 2013 revisions

    Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., Bebo, B., Calabresi, P. A., Clanet, M., Comi, G., Fox, R. J., Freedman, M. S., Goodman, A. D., Inglese, M., Kappos, L., Kieseier, B. C. & 12 others, Lincoln, J. A., Lubetzki, C., Miller, A. E., Montalban, X., O'Connor, P. W., Petkau, J., Pozzilli, C., Rudick, R. A., Sormani, M. P., Stüve, O., Waubant, E. & Polman, C. H., Jul 2014, In: Neurology. 83, 3, p. 278-286 9 p.

    Research output: Contribution to journalReviewResearchpeer-review

  63. Published

    Demyelination versus remyelination in progressive multiple sclerosis

    Bramow, S., Frischer, J. M., Lassmann, H., Koch-Henriksen, N., Lucchinetti, C. F., Sørensen, Per Soelberg & Laursen, H., 1 Oct 2010, In: Brain. 133, 10, p. 2983-98 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  64. Published

    Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis

    Sellebjerg, Finn Thorup, Hesse, D., Limborg, S., Lund, H., Søndergaard, H., Krakauer, M. & Sørensen, Per Soelberg, Feb 2012, In: Multiple Sclerosis. 19, 2, p. 179-87 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  65. Published

    Der er begrænset effekt af interferonbeta til behandling af sekundær progressiv multipel sklerose: en gennemgang af et Cochranereview

    Schreiber, K., Voldsgaard, A. & Sørensen, Per Soelberg, 2013, In: Ugeskrift for Laeger. 175, 19, p. 1342-1344 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  66. Published

    Det autonome nervesystem

    Jespersen, B. & Sørensen, Per Soelberg, 2010, Klinisk neurologi og neurokirurgi. 5 ed. København, p. 109-126 17 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterEducation

  67. Published

    Det sensoriske system

    Paulson, O. B. & Sørensen, Per Soelberg, 2010, Klinisk neurologi og neurokirurgi. 5 ed. København, p. 51-62 11 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterEducation

  68. Published

    Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study

    On behalf of the ABIRISK Consortium, O. B. O. T. A. C., Jan 2019, In: Journal of Neuroimmunology. 326, p. 19-27

    Research output: Contribution to journalJournal articleResearchpeer-review

  69. Published

    Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta

    Hermanrud, C., Ryner, M., Luft, T., Jensen, P. E., Ingenhoven, K., Rat, D., Deisenhammer, F., Sørensen, Per Soelberg, Pallardy, M., Sikkema, D., Bertotti, E., Kramer, D., Creeke, P. & Fogdell-Hahn, A., 2016, In: Journal of Immunological Methods. 430, p. 1-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  70. Published

    Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., Fujihara, K., Galetta, S. L., Hartung, H. P., Kappos, L., Lublin, F. D., Marrie, R. A., Miller, A. E., Miller, D. H., Montalban, X., Mowry, E. M. & 10 others, Sørensen, Per Soelberg, Tintoré, M., Traboulsee, A. L., Trojano, M., Uitdehaag, B. M. J., Vukusic, S., Waubant, E., Weinshenker, B. G., Reingold, S. C. & Cohen, J. A., 2018, In: Lancet Neurology. 17, 2, p. 162-173

    Research output: Contribution to journalReviewResearchpeer-review

  71. Published

    Differential microRNA expression in blood in multiple sclerosis

    Søndergaard, H. B., Hesse, D., Krakauer, M., Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 2013, In: Multiple Sclerosis. 19, 14, p. 1849-1857 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  72. Published

    Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial

    Højsgaard Chow, H., Talbot, J., Lundell, H., Gøbel Madsen, C., Marstrand, L., Lange, Theis, Mahler, M. R., Buhelt, S., Hansen, Rikke Holm, Blinkenberg, M., Romme Christensen, J., Sørensen, Per Soelberg, von Essen, Marina Rode, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2021, In: Neurology(R) neuroimmunology & neuroinflammation. 8, 5, p. 1-10

    Research output: Contribution to journalJournal articleResearchpeer-review

  73. Published

    Disability in progressive MS is associated with T2 lesion changes

    Ammitzbøll, C., Dyrby, T. B., Lyksborg, M., Schreiber, K., Ratzer, R., Romme Christensen, J., Iversen, P., Magyari, M., Garde, E., Sørensen, Per Soelberg, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2018, In: Multiple Sclerosis and Related Disorders. 20, p. 73-77

    Research output: Contribution to journalJournal articleResearchpeer-review

  74. Published

    Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects

    Cohen, J. A., Reingold, S. C., Polman, C. H., Wolinsky, J. S., International Advisory Committee on Clinical Trials in Multiple Sclerosis, I. A. C. O. C. T. I. M. S. & Sørensen, Per Soelberg, 2012, In: Lancet Neurology. 11, 5, p. 467-76 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  75. Published

    Disease protection and interleukin-10 induction by endogenous interferon-β in multiple sclerosis?

    Hesse, D., Krakauer, M., Lund, H., Søndergaard, H. B., Limborg, S. J. W., Sørensen, P. S., Sellebjerg, F., Hesse, D., Krakauer, M., Søndergaard, H. B., Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, Feb 2011, In: European journal of neurology : the official journal of the European Federation of Neurological Societies. 18, 2, p. 266-72 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  76. Published

    Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRBI*1501, CCR5 deletion mutation, apolipoprotein E)

    Schreiber, K., Oturai, A. B., Ryder, L. P., Madsen, H. O., Jørgensen, O. S., Svejgaard, A. & Sørensen, Per Soelberg, 2002, In: Multiple Sclerosis. 8, p. 295-8

    Research output: Contribution to journalJournal articleResearch

  77. Published

    Dissemineret sklerose: Ny viden om ætiologi, patofysiologi og behandling

    Sørensen, Per Soelberg, 1997, In: Ugeskrift for læger. 159, p. 1409-12

    Research output: Contribution to journalJournal articleResearch

  78. Published

    Dødsfald i forbindelse med tvangsfastholdelse af svært agiterede personer bør kunne undgås

    Sørensen, Per Soelberg, 2012, In: Ugeskrift for Laeger. 174, 40, p. 2367

    Research output: Contribution to journalJournal articleResearchpeer-review

  79. Published

    ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

    Montalban, X., Gold, R., Thompson, A. J., Otero-Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S. & 7 others, Selmaj, K., Siva, A., Sørensen, Per Soelberg, Sormani, M. P., Thalheim, C., Wiendl, H. & Zipp, F., 2018, In: Multiple Sclerosis Journal. 24, 2, p. 96-120

    Research output: Contribution to journalJournal articleResearchpeer-review

  80. Published

    EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases

    Elovaara, I., Apostolski, S., Doorn, P. V., Gilhus, N. E., Hietaharju, A., Honkaniemi, J., van, S., Scolding, N., Udd, B. & Sørensen, Per Soelberg, 2008, In: European Journal of Neurology. 15, 9, p. 893-908 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  81. Published

    EFNS guidelines on diagnosis and management of neuromyelitis optica

    Sellner, J., Boggild, M., Clanet, M., Hintzen, R. Q., Illes, Z., Montalban, X., Du Pasquier, R. A., Polman, C. H., Sørensen, Per Soelberg & Hemmer, B., 1 Aug 2010, In: European Journal of Neurology. 17, 8, p. 1019-32 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  82. Published

    Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development

    Hegen, H., Millonig, A., Bertolotto, A., Comabella, M., Giovanonni, G., Guger, M., Hoelzl, M., Khalil, M., Killestein, J., Lindberg, R., Malucchi, S., Mehling, M., Montalban, X., Polman, C. H., Rudzki, D., Schautzer, F., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg & Deisenhammer, F., Apr 2014, In: Multiple Sclerosis. 20, 5, p. 577-587 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  83. Published

    Early safety and efficacy of fingolimod treatment in Denmark

    Voldsgaard, A., Koch-Henriksen, N., Magyari, M., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg & Oturai, A. B., Jan 2017, In: Acta Neurologica Scandinavica. 135, 1, p. 129-133 5 p.

    Research output: Contribution to journalJournal articleResearch

  84. Published

    Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network

    Iaffaldano, P., Lucisano, G., Butzkueven, H., Hillert, J., Hyde, R., Koch-Henriksen, N., Magyari, M., Pellegrini, F., Spelman, T., Sørensen, Per Soelberg, Vukusic, S. & Trojano, M., 2021, In: Multiple Sclerosis Journal. 27, 10, p. 1543-1555 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  85. Published

    Early versus later treatment start in multiple sclerosis: a register-based cohort study

    the Danish Multiple Sclerosis Group, T. D. M. S. G., 2018, In: European Journal of Neurology. 25, 10, p. 1262-e110

    Research output: Contribution to journalJournal articleResearchpeer-review

  86. Published

    Editorial: Challenges in the diagnosis and treatment of multiple sclerosis

    Sørensen, Per Soelberg, 2021, In: Current Opinion in Neurology. 34, 3, p. 275-276 2 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  87. Published

    Educational achievements of children of parents with multiple sclerosis: A nationwide register-based cohort study

    Moberg, J. Y., Magyari, M., Koch-Henriksen, N., Thygesen, L. C., Laursen, B. & Sørensen, Per Soelberg, Nov 2016, In: Journal of Neurology. 263, 11, p. 2229-2237 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  88. Published

    Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis

    Börnsen, L., Christensen, J. R., Ratzer, R., Oturai, A. B., Sørensen, Per Soelberg, Søndergaard, H. B. & Sellebjerg, Finn Thorup, 2012, In: P L o S One. 7, 11, p. e47578

    Research output: Contribution to journalJournal articleResearchpeer-review

  89. Published

    Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis

    Comi, G., Cook, S., Giovannoni, G., Rieckmann, P., Sørensen, Per Soelberg, Vermersch, P., Galazka, A., Nolting, A., Hicking, C. & Dangond, F., 2019, In: Multiple Sclerosis and Related Disorders. 29, p. 168-174 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  90. Published

    Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β

    Buron, M. D., Magyari, M., Chalmer, T. A., Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 2020, In: Multiple Sclerosis and Related Disorders. 39, 101894.

    Research output: Contribution to journalJournal articleResearchpeer-review

  91. Published

    Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers

    Stuve, O., Sørensen, Per Soelberg, Leist, T., Giovannoni, G., Hyvert, Y., Damian, D., Dangond, F. & Boschert, U., 2019, In: Therapeutic Advances in Neurological Disorders. 12, p. 1-16

    Research output: Contribution to journalJournal articleResearchpeer-review

  92. Published

    Effects of fingolimod in relapsing-remitting multiple sclerosis

    Sørensen, Per Soelberg, Jun 2014, In: Lancet Neurology. 13, 6, p. 526-527 2 p.

    Research output: Contribution to journalComment/debateResearch

  93. Published

    Effects of neutralizing antibodies to interferon beta in multiple sclerosis: a logical paradox

    Sørensen, Per Soelberg, 2012, In: Multiple Sclerosis. 18, 2, p. 131-2 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  94. Published

    Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

    Giovannoni, G., Sørensen, Per Soelberg, Cook, S., Rammohan, K. W., Rieckmann, P., Comi, G., Dangond, F., Hicking, C. & Vermersch, P., May 2019, In: Multiple Sclerosis Journal. 25, 6, p. 819-827

    Research output: Contribution to journalJournal articleResearchpeer-review

  95. Published

    Employment, disability pension and income for children with parental multiple sclerosis

    Moberg, J. Y., Laursen, B., Koch-Henriksen, N., Thygesen, L. C., Brødsgaard, A., Sørensen, Per Soelberg & Magyari, M., 28 Sep 2017, In: Multiple Sclerosis. 23, 8, p. 1148-1156 9 p.

    Research output: Contribution to journalLetterResearchpeer-review

  96. Published

    Endogenous and recombinant type I interferons and disease activity in multiple sclerosis

    Sellebjerg, Finn Thorup, Krakauer, M., Limborg, S., Hesse, D., Lund, H., Langkilde, Annika Reynberg, Søndergaard, H. B. & Sørensen, Per Soelberg, 2012, In: P L o S One. 7, 6, p. e35927

    Research output: Contribution to journalJournal articleResearchpeer-review

  97. Published

    Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis

    Börnsen, L., Christensen, J. R., Ratzer, R., Hedegaard, C. J., Søndergaard, H. B., Krakauer, M., Hesse, D., Nielsen, C. H., Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 2015, In: P L o S One. 10, 3, p. 1-20 20 p., e0118830.

    Research output: Contribution to journalJournal articleResearchpeer-review

  98. Published

    Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

    Amato, M. P., Derfuss, T., Hemmer, B., Liblau, R., Montalban, X., Sørensen, Per Soelberg, Miller, D. H. & 2016 ECTRIMS Focused Workshop Group, 2. E. F. W. G., 2018, In: Multiple Sclerosis Journal. 24, 5, p. 590-603

    Research output: Contribution to journalJournal articleResearchpeer-review

  99. Published

    Epilepsi og seksualitet

    Sørensen, Per Soelberg, Jensen, P. & Jensen, S. B., 1997, Hjerne og seksualitet. København: Handelshøjskolens Forlag, p. 185-96

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  100. Published

    Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels

    Sørensen, Per Soelberg, Paulson, Olaf B., Steiness, E. & Jansen, E. C., Jan 1981, In: Annals of Neurology. 9, 1, p. 53-7 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 Next

ID: 11025